{
    "nct_id": "NCT02390635",
    "official_title": "PET/MR, PET/CT and Whole Body MR in Newly Diagnosed Acute Myeloid Leukemia (AML)",
    "inclusion_criteria": "* Patients with newly diagnosed AML\n* Non-English speaking subjects will be included. Verbal Translation Preparative Sheet (VTPS) short form will be utilized in consenting non-English speaking subjects.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* Patients with contraindications to MR\n* Patients with a known allergy to MR contrast agents\n* Uncontrollable claustrophobia\n* Recipients of more than minimal anti-leukemia treatment, with minimal treatment defined as: leukapheresis, hydroxyurea, or Cytarabine more than 1 g per square meter.\n* Patients with secondary or relapsed AML or APL should be excluded.\n* Patients with known extramedullary leukemia\n* Positive pregnancy test in a female of childbearing potential\n* Younger than 18 years\n* Greater than 400 pounds in weight\n* Patients with uncontrolled diabetes\n* Cognitive impaired adults or prisoners will be excluded\n* Estimated glomerular filtration rate (eGFR <30) will be excluded",
    "miscellaneous_criteria": ""
}